Dennis J. McNamara

Discovery of a Potent and Selective Inhibitor of Cyclin-Dependent Kinase 4/6

Peter L. Toogood, Patricia J. Harvey, Joseph T. Repine et al. · Journal of Medicinal Chemistry · 2005 · 503 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor

David W. Fry, Alexander J. Bridges, William A. Denny et al. · Proceedings of the National Academy of Sciences · 1998 · 418 citations

Life Sciences, Biochemistry, Pharmacology +17

Substrate specificity of the protein tyrosine phosphatases.

Z.Y. Zhang, Andrea M. Thieme-Sefler, Derek Maclean et al. · Proceedings of the National Academy of Sciences · 1993 · 192 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Tyrosine Kinase Inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(Phenylamino)pyrido[<i>d</i>]pyrimidine Acrylamides as Irreversible Inhibitors of the ATP Binding Site of the Epidermal Growth Factor Receptor

Jeff B. Smaill, Brian D. Palmer, Gordon W. Rewcastle et al. · Journal of Medicinal Chemistry · 1999 · 179 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Protein Tyrosine Phosphatase Substrate Specificity: Size and Phosphotyrosine Positioning Requirements in Peptide Substrates

Zhong Yin Zhang, Derek Maclean, Dennis J. McNamara et al. · Biochemistry · 1994 · 172 citations

Life Sciences, Biochemistry, Molecular Biology +14